Prospeo
Hero Section BackgroundHero Section Background
INOVIO Pharmaceuticals

INOVIO Pharmaceuticals Revenue

Biotechnology ResearchPlymouth Meeting, Pennsylvania, United States201-500 Employees

$

INOVIO Pharmaceuticals revenue & valuation

Annual revenue$182,337
Revenue per employee$1,000
Estimated valuation?$583,478
Total funding$241,500,000

Company overview

Headquarters660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
Phone number+12674404200
Website
NAICS541714
SIC873
Keywords
HIV, Prostate Cancer, Immuno-Oncology, Immunotherapy, Cancer, Ebola, Infectious Diseases, Cervical Dysplasia, Dna Vaccines, Zika, Electroporation, Cervical Cancer, Mers, T Cells, Glioblastoma, Head And Neck Cancer, Lassa, Covid-19, Cellectra, Dna Medicines, Dna Plasmids, Hpv-Associated Cancers, Hpv-Associated Disease, Syncon, Anal Hsil, Cervical Hsil, Coronaviruses, Dmab (Dna-Encoded Monoclonal Antibodies), High-Risk Hpv, Recurrent Respiratory Papillomatosis (Rrp), Vulvar Hsil
Employees201-500
Socials

INOVIO Pharmaceuticals Email Formats

INOVIO Pharmaceuticals uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@inovio.com), used 72.5% of the time.

FormatExamplePercentage
{first name}.{last name}
john.doe@inovio.com
72.5%
{first initial}{last name}
jdoe@inovio.com
13.8%
{first initial}.{last name}
j.doe@inovio.com
10.1%
{first initial}.{last name}
j.doe@inovio.com
1.4%

About INOVIO Pharmaceuticals

INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our mission: deliver on the promise of DNA medicine for patients around the world. For more information, visit www.inovio.com.

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry
Director
Manager

Employees by Department

INOVIO Pharmaceuticals has 129 employees across 15 departments.

Departments

Number of employees

Funding Data

Explore INOVIO Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2021-02-2014$150,500,000
2024-05-1514$36,000,000
2025-01-1314$30,000,000
2025-08-0314$25,000,000

Funding Insights

$241,500,000

Total funding amount

$25,000,000

Most recent funding amount

4

Number of funding rounds

INOVIO Pharmaceuticals Tech Stack

Discover the technologies and tools that power INOVIO Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

jQuery CDN

jQuery CDN

CDN

Redux

Redux

JavaScript frameworks

Apollo

Apollo

JavaScript libraries

Matomo Analytics

Matomo Analytics

Analytics

PWA

PWA

Miscellaneous

Apache HTTP Server

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

jQuery

JavaScript libraries

PHP

PHP

Programming languages

WP-PageNavi

WP-PageNavi

WordPress plugins

WordPress

WordPress

Blogs

Matomo Tag Manager

Matomo Tag Manager

Tag managers

Frequently asked questions

INOVIO Pharmaceuticals is located in Plymouth Meeting, Pennsylvania, US.
You can reach INOVIO Pharmaceuticals at +12674404200.
INOVIO Pharmaceuticals generates an estimated annual revenue of $182,337. This revenue figure reflects the company's market position and business performance in its industry.
INOVIO Pharmaceuticals has an estimated valuation of $583,478. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
INOVIO Pharmaceuticals has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.
INOVIO Pharmaceuticals has raised a total of $241,500,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at INOVIO Pharmaceuticals

Jacqueline Shea

Chief Executive Officer

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles

INOVIO Pharmaceuticals Revenue, Funding & Valuation